APOB and polycystic ovary syndrome: In conclusion, these findings support the need for larger trials on the potential utility of screening for ACVD, cardiac dysfunction and impaired apoB-metabolism in the primary care management of CVD risk in young high-risk overweight-obese women with and without PCOS.